The Algemeiner reports: JNS.org – The Israeli-British cannabis biotech start-up CIITECH announced on Tuesday that it will fund a research project in collaboration with the Hebrew University of Jerusalem exploring methods for treating asthma with medical cannabis.
The research project will be conducted at Hebrew University’s Multidisciplinary Center on Cannabinoid Research, and led by researchers Profs. Raphael Mechoulam and Francesca Levi-Schaffer. Mechoulam, a pioneer in the medical cannabis field, discovered THC — the primary psychoactive compound in the plant — in the 1970s. Levi-Schaffer is an expert in asthma research.
The study focuses on researching the effects of the non-psychoactive cannabis compound CBD and identifying its potential inhibitory effect on allergic airway inflammation that causes asthma attacks.
Read more here.